MRI’s impact on biopsy. (IMAGE)

Xia & He Publishing Inc.

MRI’s impact on biopsy.

Caption

In the Jönköping Region of Sweden, PSA measurements were taken for 23,802 men from November 1, 2011, to July 31, 2020, with follow-up concluded on January 31, 2021. Participants were categorized into 8 groups (see right side of the figure) based on screenings and evaluations conducted within 180 days after the initial PSA test. The study observed that about half of the men with PSA levels ranging from 3 to 20 ng/mL were diagnosed with prostate cancer without prior MRI examinations. Notably, a significant decline in the proportion of negative biopsies, from 28% to 7%, was observed. The figure illustrates the relationship between the increasing number of MRI examinations, a decrease in the number of biopsies, and an increase in the positive biopsy rate. Adapted from Robinson’s paper.7 PSA, prostate-specific antigen; MRI, magnetic response imaging.

Credit

Wenxue Ma, Xiaolei Zhao, Fenghai Zhou

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted.

License

CC BY-NC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.